Sign In
Buy GOSS
$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
Gossamer Bio (GOSS) Upgraded to Buy: What Does It Mean for the Stock?
01:32pm, Wednesday, 04'th Jan 2023
Gossamer Bio (GOSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Gossamer Bio (GOSS) Loses -13.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:17am, Wednesday, 04'th Jan 2023
Gossamer Bio (GOSS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estima
3 Short Squeeze Penny Stocks To Watch Before 2023
04:38pm, Wednesday, 28'th Dec 2022 PennyStocks
Short squeeze penny stocks to watch.
The post 3 Short Squeeze Penny Stocks To Watch Before 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
3 Short Squeeze Penny Stocks To Watch Before 2023
11:38am, Wednesday, 28'th Dec 2022
Short squeeze penny stocks to watch. The post 3 Short Squeeze Penny Stocks To Watch Before 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
10 Top Penny Stocks To Watch With High Short Interest This Week
02:39pm, Tuesday, 20'th Dec 2022
Short squeeze penny stocks to buy now or avoid entirely? The post 10 Top Penny Stocks To Watch With High Short Interest This Week appeared first on Penny Stocks to Buy, Picks, News and Information | P
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
06:38pm, Monday, 19'th Dec 2022 Benzinga
Gainers
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Axcella H
Penny Stocks Vs. Blue Chips, 3 Main Differences
11:00am, Saturday, 17'th Dec 2022 PennyStocks
Understand these key penny stocks vs. blue chips differences
The post Penny Stocks Vs. Blue Chips, 3 Main Differences appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks
Penny Stocks Vs. Blue Chips, 3 Main Differences
06:00am, Saturday, 17'th Dec 2022
Understand these key penny stocks vs. blue chips differences The post Penny Stocks Vs.
Penny Stocks To Buy Now? 6 Short Squeeze Stocks To Watch
11:08am, Friday, 16'th Dec 2022
Penny stocks to watch with higher short interest right now. The post Penny Stocks To Buy Now?
Penny Stocks To Buy Now? 3 Short Squeeze Stocks To Watch
01:21pm, Tuesday, 13'th Dec 2022
Penny stocks to watch with higher short interest right now. The post Penny Stocks To Buy Now?
Gossamer Bio: Buying The Savage Dip After A Trial 'Win' May Be Unwise
01:27pm, Thursday, 08'th Dec 2022
Gossamer Bio, Inc.'s lead candidate - Seralutinib, indicated for Pulmonary Arterial Hypertension - met its primary endpoint in the Phase 2 TORREY study. Nevertheless, investors dumped the stock - due
Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
01:04pm, Thursday, 08'th Dec 2022 Benzinga
Goldman Sachs raised Lowe's Companies, Inc. (NYSE: LOW) price target from $241 to $246. . Goldman Sachs analyst Kate McShane maintained a Buy rating on the stock. Lowe's shares fell 0.1% to $206.70
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
06:45pm, Wednesday, 07'th Dec 2022 Benzinga
Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-
Barclays Downgrades Gossamer Bio: Here's What You Need To Know
05:02pm, Wednesday, 07'th Dec 2022 Benzinga
Barclays downgraded its rating of Gossamer Bio (NASDAQ:GOSS) to Equal-Weight with a price target of $2.00, changing its price target from $18.00 to $2.00.
Shares of Gossamer Bio are trading down 16.95
What 9 Analyst Ratings Have To Say About Gossamer Bio
01:09pm, Wednesday, 07'th Dec 2022 Benzinga
Over the past 3 months, 9 analysts have published their opinion on Gossamer Bio (NASDAQ:GOSS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a co
